CHI3L1 and cancer: The combination treatment with CHI3L1 siRNA and ebractenoid F showed a synergistic effect on cancer cell migration and apoptosis compared with the single treatment with siRNA or ebractenoid F. Thus, these data confirmed that CHI3L1 is an important factor in the cancer cell growth inhibitory effect of ebractenoid F.